Crista Galli Ventures outs ‘evergreen’ fund to back European health tech startups at seed and Series A
Crista Galli Ventures, an early-stage health tech fund in Europe, is officially launching today. The conglomerate offers” case asset” — with exclusively a single LP( the Danish family office IPQ Capital) — and promises to provide portfolio companies with deep healthcare their skills and the additional runway needed to get over regulatory and efficacy obstacles and to the next stage.
Companies previously backed by Crista Galli Ventures( CGV) include Skin Analytics, which is using AI to improve diagnosis of skin cancer; Quibim, which is applying AI to the field of radiomics; and Ampersand Health, which is developing digital cares for cases with inflammatory modes such as Crohn’s disease, to refer precisely three out of 15.
Led by consultant radiologist Dr. Fiona Pathiraja, and with agencies in London and Copenhagen, CGV operates as an “evergreen” store, signify it doesn’t follow traditional five-year VC fundraising repetitions. Initially, the VC firm has $65 million in deployable — so called — case capital.
” We like to invest across the broad areas of depth tech, digital state and personalised healthcare ,” Pathiraja tells TechCrunch.” We favor technology solutions that become the lives of patients easier and better and, in a number of cases, that help support people’s health before they become cases. Responsibility of our remit is also for tech solutions within the healthcare industry that improve efficiency and productivity of providers .”
Alongside the main fund, CGV is also unveiling Crista Galli LABS, which, in part, aims for greater diversity in health tech by endorse founders from underrepresented backgrounds at the pre-seed stage. In addition to pre-seed investment, startups accepted into the program have access to mentoring and coaching from the CGV team.
” When I was in infirmary, there were parties from all backgrounds there and this was the norm …[ but] this is something that wasn’t my experience when I started investing ,” shows Pathiraja.” I am hit by how homogeneous both benefactor squads and speculation squads is likely to be. Whilst our core investment focus is seed and Series A, Crista Galli LABS gives smaller ticket sizings in superb pre-seed founders and ensures that at least 50% of these are from under-represented backgrounds. This intends those who are female, BAME, LGBT to start with .”
Read more: feedproxy.google.com